Site Overlay

Title: Overview of the current epidemiology of head and neck cancers in Ireland


Authors: Aline Brennan (1), Deirdre Murray (1)., Joe McDevitt (1), Theresa Redaniel (1)
Publication: Journal of The Irish Head and Neck Society - 2025
Issue: 3 Volume: 3
Published: January, 2025 View PDF

Background:
Head and neck cancers (ICD10 C00-C14, C30-C32) accounted for 3.3% of all invasive cancers (excluding non-melanoma skin cancers) in Ireland in 2020-2022. They were the 5th most common cancer in men and 15th most common cancer in women.

Methods:
The National Cancer Registry collects data on all new primary cancers diagnosed in Ireland. Age-standardised incidence rates (ASR) were calculated using the 2013 European standard population. Age-standardised 5-year net survival was calculated using Pohar-Perme method.

Results:
The annual average ASR of head and neck cancers 2020-2022 was 29.1/100,000 in men and 9.1/100,000 in women.
The ASRs for both men and women are increasing significantly (annual percentage change of 1.1% per year 2001-2022 and 1.3% per year 1994-2022 respectively).

5-year net survival has improved from 51% in 1994-1998 to 56% in 2014-2018 for men, and from 49% in 1994-1998 to 58% in 2014-2018 for women. Survival varies by age group with younger ages tending to have better survival and larger increases in survival over time.

Age-standardised mortality rates in both sexes show a significant decreasing trend over time.

Conclusion:
Head and neck cancers are a diverse group of cancers, showing variation in incidence, survival and mortality by site, sex, and age group.

Tell us what went wrong - include any error codes & a screenshot if possible
Upload a screenshot if you have it
Accepted file types: jpg, gif, png, pdf, heic, doc, docx, Max. file size: 50 MB.
This field is for validation purposes and should be left unchanged.

This will close in 0 seconds